Bile Acid Sequestrants Market Players:
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AstraZeneca Plc
- Ecogene
- Novartis International AG
- Sanofi S.A.
- Amgen Inc.
- Merck & Co., Inc.
- AbbVie Inc.
- GlaxoSmithKline plc.
- Octapharma AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of bile acid sequestrants is estimated at USD 23.31 billion.
The global bile acid sequestrants market size crossed USD 21.8 billion in 2025 and is likely to register a CAGR of over 7.7%, exceeding USD 45.77 billion revenue by 2035.
North America is projected to secure the leading share in the bile acid sequestrants market by 2035, supported by the widespread use of cholestyramine for relieving pruritus symptoms in liver cirrhosis patients.
Key players in the market include Pfizer Inc., AstraZeneca Plc, Ecogene, Novartis International AG, Sanofi S.A., Amgen Inc., Merck & Co., Inc., AbbVie Inc., GlaxoSmithKline plc., Octapharma AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Mochida Pharmaceutical Co., Ltd., Astellas Pharma Inc.
